๐
Date: Monday, June 16, 2025
๐ Time: 12:00 PM โ 1:00 PM Eastern Time
๐ Location: Virtual Seminar @ https://global.gotomeeting.com/join/271724949
๐งช OSD Overview
Join us for an engaging 1-hour discussion featuring:
Dr. Gabriela Hernandez Hoyos (BMS) and Dr. Ilayaraja Muthuramu (J&J)
Experts in genomic risk analysis and safety assessments of CAR T platforms
They will explore:
โ Genomic risks in lentiviral vs. gene-edited CAR T products
โ Key molecular and functional assays used in risk assessment
โ Preclinical safety challenges in autologous vs. allogeneic approaches
โ Insights from published case studies and FDA-approved testing strategies
๐ง Who Should Attend?
Scientists, researchers, and professionals working in:
- Gene and cell therapy
- Regulatory science
- Oncology R&D
- Translational medicine
๐ Why Attend?
- Hear from leaders in the field
- Participate in an open discussion on safety assessment strategies
- Gain insights into regulatory and translational approaches for CAR T therapies